| Literature DB >> 27251147 |
Raymond R Russell1, Jonathan Alexander2, Diwakar Jain3, Indu G Poornima4, Ajay V Srivastava5, Eugene Storozynsky6, Ronald G Schwartz6,7.
Abstract
With the increasing number of individuals living with a current or prior diagnosis of cancer, it is important for the cardiovascular specialist to recognize the various complications of cancer and its therapy on the cardiovascular system. This is true not only for established cancer therapies, such as anthracyclines, that have well established cardiovascular toxicities, but also for the new targeted therapies that can have "off target" effects in the heart and vessels. The purpose of this informational statement is to provide cardiologists, cardiac imaging specialists, cardio-oncologists, and oncologists an understanding of how multimodality imaging may be used in the diagnosis and management of the cardiovascular complications of cancer therapy. In addition, this document is meant to provide useful general information concerning the cardiovascular complications of cancer and cancer therapy as well as established recommendations for the monitoring of specific cardiotoxic therapies.Entities:
Keywords: Multimodality imaging; cancer therapy; cardiac complications; cardio-oncology
Mesh：
Substances：
Year: 2016 PMID： 27251147 DOI： 10.1007/s12350-016-0538-8
Source DB: PubMed Journal: J Nucl Cardiol ISSN： 1071-3581 Impact factor: 5.952